WAVEMARK CAPITAL INVESTMENT LOSSES –  INVESTORS MAY HAVE CLAIMS

WAVEMARK CAPITAL INVESTMENT LOSSES –  INVESTORS MAY HAVE CLAIMS

WAVEMARK CAPITAL INVESTMENT LOSSES –  INVESTORS MAY HAVE CLAIMS.

Call 800-500-4442 for a free consultation with Goodman & Nekvasil, P.A.

Wavemark Capital investors who suffered losses may want to have their investments reviewed.

The SEC alleges that Wavemark Capital, LLC raised approximately $9.6 million from nearly 100 investors.  Promissory Notes were sold between October 2021 and February 2025 through Wavemark Income Fund, LLC, according to the SEC.

Investors purchased promissory notes after being told their money would be used to purchase mobile homes and install them. Note-holders were allegedly promised annualized returns of 12% to 14%.

The SEC alleges that Wavemark did not purchase any mobile homes. Instead, the SEC alleges that investor money was used for Ponzi-like payments, sales commissions, debts, and operating expenses of affiliated entities.

WAVEMARK CAPITAL INVESTMENT LOSSES –  INVESTORS MAY HAVE CLAIMS.

WAVEMARK CAPITAL INVESTMENT LOSSES –  INVESTORS MAY HAVE CLAIMS.

Were You Referred to Wavemark by a Financial Professional?

Investors who were introduced or referred to Wavemark Capital by a broker, financial adviser, investment professional, insurance agent, or other intermediary may want to have the circumstances surrounding the investment reviewed.

The nature of the sales process, representations made to investors, commissions or other compensation, and the information provided before the investment was made may be relevant to potential claims.

Goodman & Nekvasil, P.A. investigates investment losses involving private securities and represents investors in FINRA arbitration and other investment-related claims.

If you invested in Wavemark Income Fund and suffered losses, call 800-500-4442 for a free consultation to discuss your investment.

Call Goodman & Nekvasil, P.A. at 800-500-4442 for a free consultation regarding potential Pacific Private Money investment losses.

Some information in this article was obtained from SEC filings, FINRA records, and other public sources reviewed on 9/22/26. If you believe any information is inaccurate, please contact our office at 1-800-500-4442.

Contact Us Today!

[]
1 Step 1
reCaptcha v3
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder